ELDN Net Income Growth
Eledon Pharmaceuticals Inc · Net Income Growth
ELDN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-773.09%period ending
ELDN TTM Net Income YoY % (-77.74% → -773.09%)
Year-over-year change
High-resolution chart · PNG
ELDN net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -773.0929% | |
| -310.2635% | |
| -26.0695% | |
| -6,587.9296% | |
| 116.6265% | |
| 82.5124% | |
| 62.3334% | |
| 99.1762% | |
| 39.4237% | |
| -22.5589% | |
| -9.2058% | |
| -277.2585% | |
| -285.2944% | |
| -147.76% | |
| -154.9296% | |
| -21.4656% | |
| -35.0972% | |
| -55.0642% | |
| -51.2691% | |
| -50.1306% | |
| -56.9157% | |
| -19.8166% | |
| -42.4708% | |
| -28.0397% | |
| -4.4356% | |
| -19.6221% | |
| -13.8358% | |
| -41.7205% | |
| -53.8962% | |
| -10.9431% | |
| -7.2354% | |
| 21.3118% | |
| 19.7929% | |
| -78.5469% | |
| 27.9341% | |
| 42.1389% | |
| 60.8816% | |
| 81.162% | |
| 59.6336% | |
| 36.7397% | |
| -1.3873% | |
| -36.4061% | |
| -93.5397% | |
| -78.1188% | |
| -77.7364% |